Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
March 25, 2009
Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization
Galen M Pieper, Irina A Ionova, Brian C Cooley, et al.
Blood
|
May 9, 2015
A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development
Paul E R Ellery, Susan A Maroney, Brian C Cooley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 16, 2016
Mice Expressing Low Levels of CalDAG-GEFI Exhibit Markedly Impaired Platelet Activation With Minor Impact on Hemostasis
Raymond Piatt, David S Paul, Robert H Lee, et al.
Blood
|
December 25, 2012
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo
Huiying Zhi, Lubica Rauova, Vincent Hayes, et al.
Blood
|
November 15, 2003
Cause-effect relation between hyperfibrinogenemia and vascular disease
Bryce Kerlin, Brian C Cooley, Berend H Isermann, et al.
Blood
|
March 25, 2017
Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions
Moua Yang, Brian C Cooley, Wei Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 1, 2013
Elevated prothrombin promotes venous, but not arterial, thrombosis in mice
Maria M Aleman, Bethany L Walton, James R Byrnes, et al.
Bioactive Materials
|
December 31, 2025
Ascorbate elastomer-coated ePTFE grafts inhibit neointimal hyperplasia and enhance vascular healing
Lu Yu, Emily R Newton, David C Gillis, et al.
Biomaterials Science
|
July 27, 2021
Coating small-diameter ePTFE vascular grafts with tunable poly(diol-co-citrate-co-ascorbate) elastomers to reduce neointimal hyperplasia
Lu Yu, Emily R Newton, David C Gillis, et al.
The Journal of Clinical Investigation
|
July 11, 2006
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
Qizhen Shi, David A Wilcox, Scot A Fahs, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
The Journal of Pharmacology and Experimental Therapeutics
|
March 25, 2009
Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization
Galen M Pieper, Irina A Ionova, Brian C Cooley, et al.
Blood
|
May 9, 2015
A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development
Paul E R Ellery, Susan A Maroney, Brian C Cooley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 16, 2016
Mice Expressing Low Levels of CalDAG-GEFI Exhibit Markedly Impaired Platelet Activation With Minor Impact on Hemostasis
Raymond Piatt, David S Paul, Robert H Lee, et al.
Blood
|
December 25, 2012
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo
Huiying Zhi, Lubica Rauova, Vincent Hayes, et al.
Blood
|
November 15, 2003
Cause-effect relation between hyperfibrinogenemia and vascular disease
Bryce Kerlin, Brian C Cooley, Berend H Isermann, et al.
Blood
|
March 25, 2017
Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions
Moua Yang, Brian C Cooley, Wei Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 1, 2013
Elevated prothrombin promotes venous, but not arterial, thrombosis in mice
Maria M Aleman, Bethany L Walton, James R Byrnes, et al.
Bioactive Materials
|
December 31, 2025
Ascorbate elastomer-coated ePTFE grafts inhibit neointimal hyperplasia and enhance vascular healing
Lu Yu, Emily R Newton, David C Gillis, et al.
Biomaterials Science
|
July 27, 2021
Coating small-diameter ePTFE vascular grafts with tunable poly(diol-co-citrate-co-ascorbate) elastomers to reduce neointimal hyperplasia
Lu Yu, Emily R Newton, David C Gillis, et al.
The Journal of Clinical Investigation
|
July 11, 2006
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
Qizhen Shi, David A Wilcox, Scot A Fahs, et al.
Page
of 7